Vena Vitals vs ElevenLabs
Side-by-side comparison of AI visibility scores, market position, and capabilities
Wearable blood pressure monitoring sticker with OR-grade accuracy; awaiting FDA clearance after 500+ patient clinical studies for hospital surgery and home cardiovascular monitoring.
About
Vena Vitals is a medical device company developing wearable continuous blood pressure monitoring technology — manufacturing adhesive sensor stickers that provide operating room-grade blood pressure accuracy using photoplethysmography (PPG) and proprietary algorithms, without the discomfort or interruption of traditional cuff-based blood pressure measurement. Founded in 2019 in Irvine, California, Vena Vitals has completed clinical studies on 500+ patients and is preparing its FDA submission for clearance to market the device for in-hospital (surgical and critical care) and home monitoring applications.\n\nVena Vitals' wearable patch applies to the wrist or finger and continuously monitors blood pressure beat-by-beat using optical sensors — providing the continuous monitoring currently limited to invasive arterial line catheters in ICUs or intermittent readings from arm cuffs. Continuous non-invasive blood pressure monitoring is clinically valuable during surgery (where blood pressure fluctuates significantly) and for patients with cardiovascular conditions or sleep disorders where blood pressure patterns during sleep and activity provide diagnostic insight. The device targets a significant cost reduction compared to invasive arterial line monitoring.\n\nIn 2025, Vena Vitals is in the regulatory submission phase, positioning for FDA clearance that would unlock commercial deployment in hospitals and the growing consumer remote patient monitoring market. The continuous non-invasive blood pressure market is competitive — Samsung (Galaxy Watch blood pressure), Apple (researching blood pressure for Apple Watch), Withings, and medical device companies including Omron and iHealth are pursuing cuffless blood pressure monitoring. However, most consumer wearable approaches have not achieved clinical-grade accuracy, which is Vena Vitals' key differentiator. FDA clearance would position Vena Vitals for partnerships with hospital systems and RPM (remote patient monitoring) program operators.
$500M Series D at $11B valuation (Feb 2026) — largest voice AI funding round ever. $330M ARR; 1M+ developers using the API. Enterprise customers: Deutsche Telekom, Revolut, Meta, Salesforce. Voices in 32 languages; real-time cloning from 1 second of audio.
About
ElevenLabs was founded in 2022 by Piotr Dabkowski and Mati Staniszewski, two former Google and Palantir engineers who set out to break the language barrier using AI voice technology. The company specializes in AI-powered voice synthesis, cloning, and dubbing, enabling developers and enterprises to generate human-quality speech in over 30 languages. Its core technology combines deep learning models trained on massive speech datasets to produce natural-sounding voices indistinguishable from real humans.\n\nElevenLabs offers a suite of products including its flagship text-to-speech API, voice cloning tools, and an AI dubbing platform that localizes video content while preserving the speaker's original voice. Its products target a broad audience—from indie developers building audio apps to large enterprises deploying voice interfaces at scale. Key differentiators include ultra-low latency streaming synthesis, fine-grained voice customization, and a growing library of pre-built AI voices across accents and styles.\n\nElevenLabs has grown rapidly, surpassing $330M in annualized revenue and serving over 1 million developers. Enterprise clients include Deutsche Telekom, Spotify, and leading media companies. In February 2026, the company closed a $500M Series D at an $11B valuation, cementing its position as the market leader in AI voice. Its APIs power podcasts, audiobooks, video games, and customer service bots worldwide, making ElevenLabs the default infrastructure layer for AI-generated audio.
AI Visibility Head-to-Head
Capabilities & Ecosystem
Capabilities
Integrations
Also Compare
Track AI Visibility in Real Time
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.